• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

天然产物通过抑制 ACE-2 受体抑制 SARS-CoV-2 传播的作用:综述。

Role of Natural Products against the Spread of SARS-CoV-2 by Inhibition of ACE-2 Receptor: A Review.

机构信息

Teerthanker Mahaveer College of Pharmacy, Teerthanker Mahaveer University, Moradabad 244001 (UP), India.

Department of Zoology, Krishna College of Science & Information Technology, Bijnor 246701 (UP), India.

出版信息

Curr Pharm Des. 2024;30(32):2562-2573. doi: 10.2174/0113816128320161240703092622.

DOI:10.2174/0113816128320161240703092622
PMID:39041269
Abstract

A unique extreme acute breathing syndrome emerged in China and spread rapidly globally due to a newly diagnosed human coronavirus and declared a pandemic. COVID-19 was formally named by WHO, and the Global Committee on Taxonomy referred to it as extreme Acute respiratory Syndrome Coronavirus-2 (SARS-CoV-2). Currently there is no efficient method to control the extent of SARS-CoV-2 other than social distancing and hygiene activities. This study aims to present a simple medicinal strategy for combating fatal viral diseases like COVID-19 with minimum effort and intervention. Different Ayurveda medicines (, green tea, and ) inhibit virus entrance and pathogen transmission while also enhancing immunity. Piperine (1-piperoylpiperidine), as well as curcumin, combine to create an intermolecular complex (π- π) that improves curcumin bioavailability by inhibiting glucuronidation of curcumin in the liver. The receptor- binding domains of the S-protein and also the angiotensin-converting enzyme 2 receptor of the recipient organism are directly occupied by curcumin and catechin, respectively, thereby preventing viruses from entering the cell. As a result, the infection will be tolerated by the animal host.

摘要

一种独特的极急性呼吸综合征在中国出现,并由于一种新诊断的人类冠状病毒而迅速在全球传播,并被宣布为大流行。COVID-19 由世界卫生组织正式命名,全球分类学委员会将其称为严重急性呼吸系统综合征冠状病毒 2(SARS-CoV-2)。目前,除了社交距离和卫生活动外,没有有效的方法来控制 SARS-CoV-2 的传播范围。本研究旨在提出一种简单的药用策略,以最小的努力和干预来对抗 COVID-19 等致命性病毒疾病。不同的阿育吠陀药物(姜黄素、绿茶和胡椒碱)可以抑制病毒进入和病原体传播,同时增强免疫力。胡椒碱(1-胡椒酰基哌啶)与姜黄素结合,形成一种分子间复合物(π-π),通过抑制肝脏中姜黄素的葡萄糖醛酸化来提高姜黄素的生物利用度。S 蛋白的受体结合域和受体生物的血管紧张素转换酶 2 受体分别被姜黄素和儿茶素直接占据,从而阻止病毒进入细胞。因此,感染将被动物宿主耐受。

相似文献

1
Role of Natural Products against the Spread of SARS-CoV-2 by Inhibition of ACE-2 Receptor: A Review.天然产物通过抑制 ACE-2 受体抑制 SARS-CoV-2 传播的作用:综述。
Curr Pharm Des. 2024;30(32):2562-2573. doi: 10.2174/0113816128320161240703092622.
2
Therapeutic Approach against 2019-nCoV by Inhibition of ACE-2 Receptor.通过抑制 ACE-2 受体对抗 2019-nCoV 的治疗方法。
Drug Res (Stuttg). 2021 Apr;71(4):213-218. doi: 10.1055/a-1275-0228. Epub 2020 Nov 12.
3
Therapeutic Approach Against 2019-nCoV by Inhibition of the ACE-2 receptor.通过抑制ACE-2受体对抗2019新型冠状病毒的治疗方法。
Drug Res (Stuttg). 2020 Dec 23. doi: 10.1055/a-1337-4462.
4
Phytomedical compounds as promising therapeutic agents for COVID-19 targeting angiotensin-converting enzyme 2: a review.植物药化合物作为针对血管紧张素转换酶 2 的 COVID-19 有希望的治疗剂:综述。
J Pharm Pharmacol. 2024 Oct 3;76(10):1239-1268. doi: 10.1093/jpp/rgae101.
5
Interactions between ACE2 and SARS-CoV-2 S Protein: Peptide Inhibitors for Potential Drug Developments Against COVID-19.ACE2 与 SARS-CoV-2 S 蛋白相互作用:针对 COVID-19 的潜在药物开发的肽抑制剂。
Curr Protein Pept Sci. 2021;22(10):729-744. doi: 10.2174/1389203722666210916141924.
6
Identification of natural compounds as SARS-CoV-2 entry inhibitors by molecular docking-based virtual screening with bio-layer interferometry.基于分子对接的虚拟筛选与生物层干涉法鉴定 SARS-CoV-2 进入抑制剂的天然化合物。
Pharmacol Res. 2021 Oct;172:105820. doi: 10.1016/j.phrs.2021.105820. Epub 2021 Aug 14.
7
Current approaches for target-specific drug discovery using natural compounds against SARS-CoV-2 infection.利用天然化合物靶向 SARS-CoV-2 感染的药物发现的当前方法。
Virus Res. 2020 Dec;290:198169. doi: 10.1016/j.virusres.2020.198169. Epub 2020 Sep 24.
8
Catechin and curcumin interact with S protein of SARS-CoV2 and ACE2 of human cell membrane: insights from computational studies.表没食子儿茶素没食子酸酯和姜黄素与 SARS-CoV2 的 S 蛋白和人细胞膜 ACE2 的相互作用:来自计算研究的见解。
Sci Rep. 2021 Jan 21;11(1):2043. doi: 10.1038/s41598-021-81462-7.
9
Screening S protein - ACE2 blockers from natural products: Strategies and advances in the discovery of potential inhibitors of COVID-19.从天然产物中筛选 S 蛋白-血管紧张素转化酶 2(ACE2)抑制剂:COVID-19 潜在抑制剂发现的策略和进展。
Eur J Med Chem. 2021 Dec 15;226:113857. doi: 10.1016/j.ejmech.2021.113857. Epub 2021 Oct 4.
10
Inhibition of S-protein RBD and hACE2 Interaction for Control of SARSCoV- 2 Infection (COVID-19).抑制 S 蛋白 RBD 和 hACE2 相互作用以控制 SARS-CoV-2 感染(COVID-19)。
Mini Rev Med Chem. 2021;21(6):689-703. doi: 10.2174/1389557520666201117111259.

本文引用的文献

1
Therapeutic Approach against 2019-nCoV by Inhibition of ACE-2 Receptor.通过抑制 ACE-2 受体对抗 2019-nCoV 的治疗方法。
Drug Res (Stuttg). 2021 Apr;71(4):213-218. doi: 10.1055/a-1275-0228. Epub 2020 Nov 12.
2
Good or bad: Application of RAAS inhibitors in COVID-19 patients with cardiovascular comorbidities.好与坏:RAAS 抑制剂在合并心血管疾病的 COVID-19 患者中的应用。
Pharmacol Ther. 2020 Nov;215:107628. doi: 10.1016/j.pharmthera.2020.107628. Epub 2020 Jul 9.
3
Virtual Screening of Natural Products against Type II Transmembrane Serine Protease (TMPRSS2), the Priming Agent of Coronavirus 2 (SARS-CoV-2).
天然产物对 II 型跨膜丝氨酸蛋白酶(TMPRSS2),即冠状病毒 2(SARS-CoV-2)的启动剂的虚拟筛选。
Molecules. 2020 May 12;25(10):2271. doi: 10.3390/molecules25102271.
4
In silico screening of natural compounds against COVID-19 by targeting Mpro and ACE2 using molecular docking.基于分子对接技术靶向 Mpro 和 ACE2 对 COVID-19 进行天然化合物的计算机筛选。
Eur Rev Med Pharmacol Sci. 2020 Apr;24(8):4529-4536. doi: 10.26355/eurrev_202004_21036.
5
Profile of a killer: the complex biology powering the coronavirus pandemic.杀手剖析:驱动新冠疫情的复杂生物学机制
Nature. 2020 May;581(7806):22-26. doi: 10.1038/d41586-020-01315-7.
6
Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19.住院 COVID-19 合并高血压患者中血管紧张素转换酶抑制剂和血管紧张素 II 受体阻滞剂的住院使用率与死亡率的关系。
Circ Res. 2020 Jun 5;126(12):1671-1681. doi: 10.1161/CIRCRESAHA.120.317134. Epub 2020 Apr 17.
7
Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System: Celebrating the 20th Anniversary of the Discovery of ACE2.血管紧张素转换酶 2:SARS-CoV-2 受体和肾素-血管紧张素系统的调节剂:庆祝 ACE2 发现 20 周年。
Circ Res. 2020 May 8;126(10):1456-1474. doi: 10.1161/CIRCRESAHA.120.317015. Epub 2020 Apr 8.
8
COVID-19, SARS and MERS: are they closely related?新型冠状病毒肺炎、严重急性呼吸综合征和中东呼吸综合征:它们有何关联?
Clin Microbiol Infect. 2020 Jun;26(6):729-734. doi: 10.1016/j.cmi.2020.03.026. Epub 2020 Mar 28.
9
Research and Development on Therapeutic Agents and Vaccines for COVID-19 and Related Human Coronavirus Diseases.新型冠状病毒肺炎及相关人类冠状病毒疾病治疗药物和疫苗的研发
ACS Cent Sci. 2020 Mar 25;6(3):315-331. doi: 10.1021/acscentsci.0c00272. Epub 2020 Mar 12.
10
Discovering drugs to treat coronavirus disease 2019 (COVID-19).发现治疗2019冠状病毒病(COVID-19)的药物。
Drug Discov Ther. 2020;14(1):58-60. doi: 10.5582/ddt.2020.01012.